Bedel Financial Consulting Inc. Lowers Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bedel Financial Consulting Inc. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,252 shares of the medical equipment provider’s stock after selling 192 shares during the period. Bedel Financial Consulting Inc.’s holdings in Intuitive Surgical were worth $1,697,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in ISRG. Howard Capital Management Group LLC raised its holdings in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after acquiring an additional 92 shares in the last quarter. Farther Finance Advisors LLC grew its holdings in shares of Intuitive Surgical by 35.1% during the third quarter. Farther Finance Advisors LLC now owns 2,900 shares of the medical equipment provider’s stock worth $1,425,000 after purchasing an additional 754 shares in the last quarter. Chicago Partners Investment Group LLC increased its position in shares of Intuitive Surgical by 1.4% in the third quarter. Chicago Partners Investment Group LLC now owns 2,461 shares of the medical equipment provider’s stock worth $1,261,000 after purchasing an additional 33 shares during the last quarter. Clear Creek Financial Management LLC raised its stake in Intuitive Surgical by 4.4% in the third quarter. Clear Creek Financial Management LLC now owns 1,551 shares of the medical equipment provider’s stock valued at $762,000 after purchasing an additional 66 shares in the last quarter. Finally, Optas LLC increased its holdings in shares of Intuitive Surgical by 13.4% in the 3rd quarter. Optas LLC now owns 651 shares of the medical equipment provider’s stock worth $320,000 after buying an additional 77 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $566.98 on Tuesday. The firm has a market capitalization of $201.95 billion, a P/E ratio of 88.45, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business has a fifty day moving average of $570.66 and a 200 day moving average of $530.08.

Analyst Ratings Changes

A number of equities analysts recently weighed in on ISRG shares. Bernstein Bank raised their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Citigroup increased their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 12,598 shares of company stock valued at $7,223,467. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.